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Severe Obesity and Left Ventricular Geometry
Giovanni de Simone
Obesity is a condition encompassing a broad range ofclinical presentations from a nearly normal status toa life-threatening disease. In the absence of a perme-
ating campaign raising the level of attention to the problem of
obesity, many obese individuals see their doctors only for
esthetic reasons. A large number of subjects, in fact, seem to
live quite well even with moderate or severe obesity. Others,
albeit feeling healthy, look for dietary interventions not only
to improve their body build but also to increase the level of
their self-esteem. Some others, a minority, usually those in
class III,1 progressively develop symptoms and clinical signs
that raise their level of attention and force them to see
doctors.
The latter type of obese subjects is usually more motivated
and, therefore, tends to be more compliant with physicians’
suggestions and indications. There is a proportion of these
individuals who are considered to be at higher risk, and when
their motivations are strong enough, they are sent to bariatric
surgery. When examining those obese subjects, doctors and
researchers need to be aware that they represent the tip of the
iceberg, far away from the reality of obesity in general and from
the real cardiovascular risk attributable to obesity in population.
Because of the a priori selection, hypertension, diabetes, joint
pain, and whatever comorbidity is limiting quality of life are
very frequent in those patients. Their cardiovascular risk is
higher than in obese patients without prevalent comorbidities,
and, unsurprisingly, they also show high levels of left ventricular
(LV) mass partly related to coexisting abnormalities consistent
with findings in the setting of the metabolic syndrome.2,3
Abnormalities of LV geometry get worse as the severity of
morbid obesity increases.
In this issue of the journal, Avelar et al4 add another
important observation by focusing their study on the effect of
obstructive sleep apnea–hypopnea on levels of LV mass in
obese patients with some compelling indications for bariatric
surgery. The vast majority of these patients were women.
Although the authors used a method of normalization of LV
mass that minimizes the gender difference, there is, however,
gender difference in the distribution of obstructive sleep
apnea–hypopnea episodes and, most likely, in their severity,
as also confirmed in recent works.5,6 Although the effort of
breathing is not necessarily different in men and women
when lying the same, the physiology of breathing is different
in men and women even in the presence of similar obstructive
conditions, particularly when excessive abdominal fat com-
presses the diaphragm toward the chest.
Even considering the potential gender-related limitations,
the observation by Avelar et al4 that the degree of sustained
nocturnal hypoxemia, rather than the number of apneic and
hypopneic episodes, contributes to the variance of LV mass
index is interesting, because it indicates a real measurable
biological characteristic potentially associated with LV mass.
Focusing on hypoxemia overcomes, at least in part, doubts
that might be raised by the use of the apnea–hypopnea index
as a raw measure of this sleep disturbance. The apnea–
hypopnea index is the number of nocturnal apnea or hypop-
nea episodes normalized by the number of hours of sleep, but
its accuracy is substantially limited by the difficulty to
standardize a measure of hypopnea because of both technical
problems related to measurements of air flow through the
respiratory airway during sleep and significant differences
between men and women.7 In contrast with the raw indication
provided by apnea–hypopnea index, the evaluation of sus-
tained hypoxemia focuses on potential pathophysiologic
mechanisms related to the effect of sleep disorders on the
cardiovascular system. As the oxygen saturation in the blood
decreases and thoracic pressure changes because of obstruc-
tion, a number of autonomic, humoral, neurohormonal, and
hemodynamic changes take place, which affect the cardio-
vascular system even during the day.8 Most changes might go
back to normality once obstructive sleep apnea is treated and
improved.9,10 Sympathetic stimulation because of sustained
hypoxemia is particularly insidious,11 and although not di-
rectly measured, it is likely present also in the population
sample of Avelar et al4 as is suggested by the higher heart
rate. Sympathetic hypertone can worsen insulin resistance
and can modulate leptin expression in a way that facilitates
the development of a vicious cycle, worsens obesity, and
promotes the related comorbidities.8
Other well-studied mechanisms related to obstructive sleep
apnea–hypopnea involve endothelial dysfunction and hypoxia-
related expression of proinflammatory cytokines.12–14 A com-
bination of inflammation and vasoconstrictive stimuli largely
accounts for the high blood pressure in these patients and
for the difficulty to optimally control their values.15 In the
morbid obese population in the study by Avelar et al,4 body
mass index and nocturnal saturation of O2 account for most of
the explained variance of LV mass in addition to systolic
blood pressure measured at the office visit. The relatively
poor effect of office systolic blood pressure on the variance
of LV mass is not different from what has been reported
previously in many studies, also in the absence of antihy-
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pertensive therapy,16 but in this case, it might be further
disturbed by the ongoing antihypertensive therapy. Values of
blood pressure taken at the office visit might not reflect the
real blood pressure load imposed on the left ventricle during
the day.17 A good control of office blood pressure in hyperten-
sive subjects does not mean a good control of blood pressure
throughout the day.
In particular, a normal or high-normal blood pressure
measured at the office visit might underestimate the 24-
hour blood pressure load in obese subjects, especially when
comorbidities are present. The obesity-associated insulin-
resistance blunts the activity of insulin in promoting arterial
compliance, which results in increased arterial stiffness18 and
consequent increases in central blood pressure. Masked
hypertension is found more frequently in patients with central
obesity,19 and the lack of nocturnal decrease of blood pressure
(nondipping pattern) is frequently associated with central
obesity.20 Because central fat distribution is near constant in
class II and III obesity, there are many indications that central
blood pressure and/or 24-hour blood pressure load could be
altered in the population sample of the study by Avelar et al4;
also, body mass index and hypoxemia were efficient bioas-
says of a hemodynamic pattern more complex than that
emerging from the simple office blood pressure measure-
ment. It might also be speculated that abdominal obesity and
not excess of body fat by itself plays a major role in these
findings.
In the obese population of the study by Avelar et al,4 the
presence of a masked high 24-hour blood pressure overload
might, in part, explain the high prevalence of concentric LV
geometry. The proportion of subjects with concentric LV
geometry is, in fact, substantially higher than would be
expected by the general assumption that obesity is associated
with a predominant volume overload. An unexpected high
prevalence of concentric LV geometry in obesity has already
been reported in the current literature,21,22 a finding that is
often undervalued or even neglected. The proportion of
concentric LV geometry could also be higher in the popula-
tion sample of Avelar et al,4 because of the relatively young
average age. We have shown previously that the relationship
between wall thickness and LV cavity dimension increases
with increasing age,23 and in the study by Avelar et al,4 the
partition values used to classify concentric LV geometry were
high and, therefore, more fitting with an older population.
There are many reasons to explain the prevalence of concen-
tric LV geometry in morbid obesity. In addition to the possibility
of high blood pressure load, direct neurohormonal activation
(including sympathetic overactivity, increased expression of
endothelin and reduced production of nitroxide activated by
hypoxemia,8 and increased in blood viscosity)24,25 might con-
tribute to hemodynamic and local conditions26 yielding concen-
tric LV remodeling. Reverting the construction stimulated by the
Avelar et al4 study, these considerations also open the possibility
that the phenotypic presentation of a young obese subject with
high-normal office blood pressure and concentric LV geometry
might carry a high probability of obstructive sleep apnea–
hypopnea syndrome, thus, raising the possibility of identifying
subjects eligible for a sleep study. Eventually, focus on accurate
analysis of LV geometry in obese subjects might provide more
information in the future to refine our ability to stratify cardio-
vascular risk.
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